This is reflected in two articles in the current issue of the European Journal of Human Genetics that discuss the need for regulatory frameworks around
. to consider the future of clinical direct-to-consumer (DTC) genetic tests. Few corners of the personal genomics . published a short but significant article in the journal .
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine (NEJM) has . large body of data we have to allay concerns around consumer .
. for Educating the Next Generation of Nurses on Genetics and Genomics in the 21st Century. Journal of . Position statement: Direct to consumer genetic testing. Retrieved May 26 .
By Turna Ray A study published this week in the New England Journal of Medicine found that genomic data did not lead to any short-term changes in people's psychological health .
Genomics Society and Policy Journal is a peer-reviewed academic online journal that provides an outlet . of proportion: two thoughts about the governance of direct-to-consumer .
Browse all our work. Reports; Journal publications; Consultation journal of consumer genomics responses .
journal of consumer genomics
over-the-counter in the United States (US) (see previous news), the world of consumer genomics .
The Wall Street Journal reports that personalized medicine is gathering speed: . Even at this early stage of consumer genomics and personalized medicine, consumers can already .
As US and Australian regulators struggle to provide guidelines on direct-to-consumer genomics . Rather than fork out $1000 for a genome scan, the New England Journal of Medicine .
The European Journal of Human Genetics is the official Journal of . pressing along with the recent proliferation of personal genomics companies: it is indeed the role of consumer .
The New England Journal of Medicine (NEJM) is telling doctors what they should advise . Consumer Genomics and Personalized Medicine. NEJM Focus on Genomewide Scans.
. of Michigan School of Public Health will work with consumer genetics companies 23andMe and Pathway Genomics
Author: